Hatem Amer, MD, FASN, FAST

Transplant Nephrologist, Associate Professor of Medicine, Mayo Clinic. Tweets are my own.

[Wisit Cheungpasitporn MD FACP | FASN | FAST @wisit661]

😊🙏🏻 Happy to share our newly published article in 📢💊
"Protocol-constrained AI enhances tacrolimus dosing accuracy in kidney transplant care"

🔗 Read the full open-access article here: https://t.co/7aEbhONNKB

Tacrolimus dosing after a kidney transplant is highly complex, individualized, and prone to variability. To help address this, our team developed TacroDose AI—a protocol-constrained large language model (LLM) designed to generate dosing recommendations that strictly align with established institutional guidelines.
💡 Key Findings:
🔹 After refining our model with structured output verification (TacroAI 2.0), we achieved a remarkable 91.7% protocol adherence.
🔹 Crucially, we reduced sentinel errors to just 1.0% and significantly improved reproducibility.
🔹 This provides a powerful framework for integrating generative AI with rule-based clinical protocols to support safe, clinician-supervised medication management in transplant care.
A huge congratulations to my outstanding mentee and first author, Benjamin Bizer, and our fantastic fellows who drove this project! 👏✨ I am so incredibly grateful to collaborate with this brilliant team: Oscar A Garcia Valencia, Flora Kincses, Jose Arriola-Montenegro, Charat Thongprayoon, and Jing Miao, Wisit Cheungpasitporn. @josearriolam @OscarGarciaMD @jingmiao2019 @MayoClinicNeph @FrontiersIn

Wisit Cheungpasitporn, MD, FACP, FASN, FAST
Clinician-Scientist & Professor of Medicine, Mayo Clinic
Leading AI Innovation in Kidney Care
#KidneyTransplant #Nephrology #ArtificialIntelligence #GenerativeAI #Tacrolimus #DigitalHealth #ClinicalDecisionSupport #MedicalEducation #HealthcareAI #FutureOfMedicine #MayoClinic

[Ladan Zand @LadanZand]

In this article I argue against using clinical remission as an endpoint for stopping IS therapy in lupus nephritis! There is a pro position, as well as moderator commentary. Hope you enjoy it! @asnpublications

https://t.co/zl4Q1ZkvCj

[Hatem Amer, MD, FASN, FAST @h4amer]

Proud of our 2025-2026 transplant nephrology fellows. 2/5 young innovator awardees at CEOT. ⁦@MayoClinicNeph⁩ ⁦@MayoTransplant⁩

[Wisit Cheungpasitporn MD FACP | FASN | FAST @wisit661]

😃✨ Last Day of the KDIGO Controversies Conference on Technological Advancements to Support Guideline-Informed Care (20–23 November 2025, Madrid 🇪🇸) @goKDIGO

Today was an inspiring final day as we presented the refined summaries, integrated feedback across all eight questions, and continued shaping a cohesive synthesis for the conference report. We also engaged in focused discussions to map out the key research gaps and research priorities that will guide future work in technology-enabled, guideline-informed kidney care. 💡

🙏 We are grateful for the opportunity to collaborate with such an exceptional group of global colleagues whose insights and dedication continue to push the field forward. @FrancescoPesce

🤝 Looking ahead, we are excited for the continued partnerships, shared learning, and innovative projects that will emerge from this week.
@MayoClinicNeph

Conference link 🔗
https://t.co/b3uuO1AWNY

[Hatem Amer, MD, FASN, FAST @h4amer]

@moeltemamy @ASTSChimera @ColumbiaSurgery @CleClinicUro A truly inspirational and practical talk by Dr Ratner full of real life experiences and a framework for innovating and overcoming challenges.

[Mohamed Eltemamy @moeltemamy]

No better way to end the #DLE2025 in Egypt 🇪🇬 than chairing this amazing inspirational lecture by former @ASTSChimera president Dr. Lloyd Ratner from @ColumbiaSurgery on innovation and transforming transplantation . Now back to the 🇺🇸 @h4amer @CleClinicUro #kidney #transplant

[Hatem Amer, MD, FASN, FAST @h4amer]

Dr Pablo Moreno presenting on donor care units. ⁦@MayoTransplant⁩ ⁦@PabloMorenoGar6⁩

[Hatem Amer, MD, FASN, FAST @h4amer]

Dr Pablo Moreno presenting on donor care units. ⁦@MayoTransplant⁩ ⁦@PabloMorenoGar6⁩

[Hatem Amer, MD, FASN, FAST @h4amer]

Dr Martin Mai presenting on the evolution of kidney allocation in the US. ⁦@MayoTransplant⁩ ⁦@MayoClinicNeph⁩ ⁦@DonateLifeEG⁩ ⁦@PabloMorenoGar6⁩

[Hatem Amer, MD, FASN, FAST @h4amer]

Dr Eltenemy presenting on his series is k and spk robotic transplants. With 3 d surgical planning, lab experience and practice comprable ischemia time. ⁦@DonateLifeEG⁩

[Hatem Amer, MD, FASN, FAST @h4amer]

Dr Andrew Bentall ⁦@AJBentall⁩ presenting on ABOi transplants and the importance of precise assessment of blood group antigens and antibodies ⁦@MayoTransplant⁩ ⁦@MayoClinicNeph⁩ ⁦@DonateLifeEG⁩

[Hatem Amer, MD, FASN, FAST @h4amer]

Dr Martin Mai presenting on biomarkers in kidney transplantation. “ personalised care is hare’ ⁦@MayoTransplant⁩ ⁦@MayoClinicNeph⁩ ⁦@DonateLifeEG⁩

[Mayo Clinic Nephrology @MayoClinicNeph]

👏 So proud to see our Mayo Clinic Nephrology fellows deliver outstanding oral and poster presentations at American Society of Nephrology #KidneyWk 2025 — showcasing excellence, innovation, and collaboration.
🙏🏻 Thanks 😊 @ASNKidney
@Arjun_Mohan1 @h4amer @k1dneyMD @wisit661

[Hatem Amer, MD, FASN, FAST @h4amer]

Dr Sandra Herrman ⁦@HerrmannMd⁩ presenting at ASN on TMA/complement and anti complement therapies in cancer patients. ⁦@MayoClinicNeph⁩ ⁦@MayoClinic⁩ ⁦@MayoTransplant⁩

[Jose Arriola-Montenegro @josearriolam]

Excited to share our recently published case report on RAS. Highlighting the potential role of revascularization in select high-risk cases 🫘 👏🏽
Thanks for the opportunity and guidance @SamyRiad9 @MayoClinicNeph
https://t.co/0O3wr0TAUX

[Hatem Amer, MD, FASN, FAST @h4amer]

More scholarly productivity and comradeship ⁦@MayoMedEd⁩ ⁦@MayoClinicNeph⁩ ⁦@MayoTransplant⁩

[Hatem Amer, MD, FASN, FAST @h4amer]

Dr Sas discussing with Dr Adrogue outcomes of a novel therapy for Primary hyperoxaluria that can avoid the need for transplant. ⁦@MayoClinicNeph⁩ ⁦@AdrogueHoracio⁩

[Hatem Amer, MD, FASN, FAST @h4amer]

@Mohamme64448697

[Hatem Amer, MD, FASN, FAST @h4amer]

Dr Mohan presenting his poster to ASN Kidney week participants. We need to be on the lookout for Glomerular disease in ICI inhibitors ⁦@MayoClinicNeph⁩ ⁦@HerrmannMd⁩ ⁦@_arjunmohan_⁩ ⁦@MayoFellows⁩ ⁦@MPAlexanderMD⁩

[Hatem Amer, MD, FASN, FAST @h4amer]

Made proud again. Dr Abdelgadir presenting on the histological changes in pediatric deceased donor allografts. ⁦@MayoClinicNeph⁩ ⁦@MayoTransplant⁩ ⁦@ASNKidney⁩